Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Agenda, appeal, ASCO, Budget, Califonia, category, challenge, chosen, confidence, content, Cosmetic, create, crosswalk, CT, declining, deferral, demand, demonstrated, Deregulatory, doubled, EndoCheckSM, enforce, enforcement, examination, explicit, FDC, fewer, foundation, grace, highly, histologically, Hombeck, impossible, intent, intention, intervention, introduction, IVCT, laparoscopy, longitudinal, LPC, Marlene, matter, McLennan, newly, noninvasive, notification, OMB, OVAInheritSM, owner, Parnell, percentage, physical, premarket, print, proliferation, prudent, registry, relocation, remote, request, rulemaking, salesperson, sample, seasonally, Secretary, session, Shelton, simultaneously, SM, solid, spring, steady, subtenant, suitability, suspension, theanagementt, threshold, Torsten, trend, unclear, unique, unprofitable, usage, Verifying, vitro, Winfred, written
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view